CME Group names Chen director, financial research and product development

CME Group, the world's largest and most diverse derivatives exchange, today announced that it has named Yue (Nina) Chen as Director, Financial Research and Product Development.

Be the first to comment

External

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author.

In this newly created position, Chen, 31, will be responsible for identifying and developing new product and clearing opportunities in the over-the-counter (OTC) markets. Her primary focus will be on credit markets, but will also extend into other asset classes including equities, commodities and fixed income. She will report to Eugene Mueller, Director, Financial Research and Product Development.

Prior to joining CME Group, Chen most recently served as Vice President, Goldman Sachs Asset Management, where she was a junior portfolio manager on global structured credit products. She also worked at Goldman Sachs as a strategist for U.S. interest rate products, including mortgage-backed securities, interest rate swaps and swaptions.

Chen earned her bachelor's degree in chemical engineering from Tsinghua University in Beijing, China and her PhD in chemical engineering from the Massachusetts Institute of Technology. She is fluent in Mandarin.

Sponsored [Webinar] Automated Testing: The road to Evergreen Compliance

Comments: (0)

[On-Demand Webinar] Banks and Credit Unions: How to Establish the Core Banking BlueprintFinextra Promoted[On-Demand Webinar] Banks and Credit Unions: How to Establish the Core Banking Blueprint